BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 548213)

  • 1. Clomipramine: plasma levels and clinical effects.
    Reisby N; Gram LF; Bech P; Sihm F; Krautwald O; Elley J; Ortmann J; Christiansen J
    Commun Psychopharmacol; 1979; 3(5):341-51. PubMed ID: 548213
    [No Abstract]   [Full Text] [Related]  

  • 2. Relating plasma levels of clomipramine and clinical response.
    Seldrup J
    J Int Med Res; 1980; 8 Suppl 3():96-110. PubMed ID: 7202825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--II. Report on a placebo-controlled clinical trial.
    Pecknold JC; Amin MM; Ban TA; Orbach L
    Psychopharmacol Bull; 1976 Jan; 12(1):24-5. PubMed ID: 1108078
    [No Abstract]   [Full Text] [Related]  

  • 4. Clomipramine and age: an interaction study.
    Watson JU; Beaumont G; Poole P
    J Int Med Res; 1980; 8 Suppl 3():81-4. PubMed ID: 7202822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--I. Report on an uncontrolled clinical trial.
    Campbell P; Ananth JV; Gomez L
    Psychopharmacol Bull; 1976 Jan; 12(1):23-4. PubMed ID: 1108077
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--IV. A summary report.
    Lehmann HE; Ban TA; Pecknold JC
    Psychopharmacol Bull; 1976 Jan; 12(1):27-9. PubMed ID: 1108080
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--III. Standard-controlled clinical trial.
    Pecknold JC; Gratton L; Ban TA; Klingner A
    Psychopharmacol Bull; 1976 Jan; 12(1):26-7. PubMed ID: 1108079
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical trial of a 50 mg formulation of clomipramine (Anafranil) with steady-state plasma level measurements.
    Gringras M; Luscombe DK; Jones RB; Beaumont G; Seldrup J; John V
    J Int Med Res; 1977; 5(1 Suppl):119-24. PubMed ID: 863081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clomipramine and smoking: an interaction study--clinical findings.
    Gostick N; Beaumont G; Grieve A
    J Int Med Res; 1980; 8 Suppl 3():85-7. PubMed ID: 7202823
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Postgrad Med J; 1980; 56 Suppl 1():130-3. PubMed ID: 7393823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing.
    John VA; Luscombe DK; Kemp H
    J Int Med Res; 1980; 8 Suppl 3():88-95. PubMed ID: 7202824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS; Marks IM; Wright J; Luscombe DK
    Postgrad Med J; 1980; 56 Suppl 1():134-9. PubMed ID: 7393824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between clinical response, plasma levels and side-effects of clomipramine (Anafranil) in general practitioner trials.
    Miller P; Luscombe DK; Jones RB; Seldrup J; Beaumont G; John V
    J Int Med Res; 1977; 5(1 Suppl):108-18. PubMed ID: 863079
    [No Abstract]   [Full Text] [Related]  

  • 15. Anafranil in obsessive compulsive neurosis.
    Wyndowe J; Solyom L; Ananth J
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):611-7. PubMed ID: 812637
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of clomipramine in phobic patients. Preliminary research report.
    Carey MS; Hawkinson R; Kornhaber A; Wellish CS
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):107-10. PubMed ID: 806423
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparisons of various clomipramine (Anafranil) dosage regimes.
    Frank P
    J Int Med Res; 1977; 5(1 Suppl):11-5. PubMed ID: 863080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level studies of clomipramine and desmethylclomipramine following intravenous infusions of clomipramine in depressive patients.
    Luscombe DK; Wright J; Jain VK
    Postgrad Med J; 1977; 53 Suppl 4():88-96. PubMed ID: 600900
    [No Abstract]   [Full Text] [Related]  

  • 19. Clomipramine plasma level and clinical response.
    Broadhurst AD; James HD; Corte LD; Heeley AF
    Postgrad Med J; 1977; 53 Suppl 4():139-45. PubMed ID: 600891
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma levels and clinical improvement--a comparative study of clomipramine and amitriptyline in depression.
    Moyes IC; Ray RL; Moyes RB
    Postgrad Med J; 1980; 56 Suppl 1():127-9. PubMed ID: 7393822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.